Baxter International specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows:
- systems for delivering medications and intravenous therapy (56,1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc. The group also provides kidney dialysis drugs and equipments;
- medicines and medical devices (43.9%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.).
At the end of 2012, the group had more than 50 production sites worldwide.
Net sales break down geographically as follows: the United States (42.7%), Europe (29.6%), Asia/Pacific (15.7%), Latin America and Canada (12%).
|
